Sadik Kassim

Sadik Kassim is the chief technology officer for genomic medicines at Danaher Corporation, where he played a key role in the collaboration that enabled the rapid production of a custom gene-editing treatment for a baby, highlighting the potential for expedited development of personalized therapies.